Dr. Nathaniel Rosso Smilowitz, MD

Dr. Smilowitz practices at NYU Langone - Tisch Hospital in New York, New York.

Dr. Smilowitz's NPI, 1437475696, was assigned on April 13, 2010. Dr. Smilowitz graduated from New York University School of Medicine in 2010. Dr. Smilowitz holds New York license 262021.

Dr. Smilowitz's primary practice is NYU Langone - Tisch Hospital, at 550 1st Ave, New York, NY 10016 in New York County. The practice phone is (212) 263-1481.

Dr. Smilowitz's primary practice is NYU Langone - Tisch Hospital in New York, New York. Dr. Smilowitz is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smilowitz practices. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Smilowitz's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Smilowitz is licensed in New York.

CMS data shows 50 Medicare services from Dr. Smilowitz across 3 procedure codes in 2024, for 32 Medicare patients. Medicare paid $5,480 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 32 Medicare patients who saw Dr. Smilowitz in 2024. The largest group is 65 to 74, with 15 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 2.86, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Smilowitz's median patient age at 65, with 40% women.

In 2017, Dr. Smilowitz wrote 49 Medicare Part D claims. They cover 3 drugs, with $384 in total drug cost. In 2016, CMS named 251 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Smilowitz for performance year 2024, reported as part of a group. Dr. Smilowitz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Coronary angioplasty and stenting: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 164 papers to Dr. Smilowitz, published from 2012 to 2025. 2022 was the busiest year, with 16. The most frequent topics are Myocardial Infarction, Coronary Angiography and Coronary Artery Disease. Dr. Smilowitz has published most often in Am J Cardiol. Dr. Smilowitz's most frequent co-authors are Jeffrey Berger, MBA, MD, Judith S. Hochman, MD and Stuart David Katz, MD.

Dmand AI links Dr. Smilowitz to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Ischemia and Coronary Artery Disease.

CMS Open Payments shows 74 general payments to Dr. Smilowitz from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Abbott Laboratories paid the most, $41,337.

Dr. Smilowitz graduated from New York University School of Medicine in 2010.